BeamMed develops, manufactures, and markets bone-related screening, diagnostic, and monitoring solutions. The company produces ultrasound technology and devices that enable physicians to provide early assessment, diagnosis, and monitoring of osteoporosis, as well as to assess bone growth.
BeamMed's line of devices is based on the patented Omnipath axial transmission technology, a quantitative ultrasound technology that has been proven to offer a high level of accuracy and patient safety. The Sunlight Omnisense 9000 Quantitative Ultrasound Bone Sonometer delivers a fast, user-friendly assessment of osteoporosis, enabling cost-effective early assessment, diagnosis, and monitoring of the disease.
The lightweight MiniOmni Quantitative Ultrasound device is a portable bone sonometer that also enables physicians to provide early assessment, diagnosis, and monitoring of osteoporosis. The MiniOmni meets the standard requirement of NCQA HEDIS OMW measure and is used by payers and providers in the United States to close HEDIS gaps and improve Medicare quality scores. The MiniOmni is used in primary care facilities such as clinics and checkup centers, as well as in home visits.